Despite advanced knowledge on the genetic basis of oxidative phosphorylation-related diseases, the molecular and/or cellular determinants for tissue-specific dysfunction are not completely understood. Here, we report the cellular events associated with mitochondrial respiratory Complex II deficiency occurring before cell death. Mutation Leigh's syndrome is a rare but severe and fatal encephalopathy of early childhood that is most frequently associated with deficiencies in nucleus-encoded subunits of Complex I (NDUFS3 and NDUFS7), 4, 5 Complex II (SDHA), 6 Complex IV (SURF1) 7 or pyruvate dehydrogenase. 8 Despite the identification of the genetic origin of Leigh's syndrome, the molecular and cellular events associated with pathology are not completely understood.
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Despite advanced knowledge on the genetic basis of oxidative phosphorylation-related diseases, the molecular and/or cellular determinants for tissue-specific dysfunction are not completely understood. Here, we report the cellular events associated with mitochondrial respiratory Complex II deficiency occurring before cell death. Mutation or chronic inhibition of Complex II determined a large increase of basal and agonist-evoked Ca 2 þ signals in the cytosol and the mitochondria, in parallel with mitochondrial dysfunction characterized by membrane potential (Dw mit ) loss, [ATP] reduction and increased reactive oxygen species production. Cytosolic and mitochondrial Ca 2 þ overload are linked to increased endoplasmic reticulum (ER) Ca 2 þ leakage, and to SERCA2b and PMCA proteasome-dependent degradation. Increased [Ca 2 þ ] mit is also contributed by decreased mitochondrial motility and increased ER-mitochondria contact sites. Interestingly, increased intracellular [Ca 2 þ ] activated on the one hand a compensatory Ca 2 þ -dependent glycolytic ATP production and determined on the second hand mitochondrial pathology. These results revealed the primary function for Ca 2 þ signalling in the control of mitochondrial dysfunction and cellular bioenergetics outcomes linked to respiratory chain Complex II deficiency. Cell Death and Differentiation (2010) 17, 1855-1866; doi:10.1038/cdd.2010.51; published online 21 May 2010 Mitochondria are the driving force behind life, as mitochondrial oxidative phosphorylation provides the main source of ATP in the cell. In addition to energy production, mitochondria have a crucial function in mediating amino-acid biosynthesis, fatty acid oxidation, intermediate metabolic pathways, free radicals production and Ca 2 þ homeostasis. 1 Mitochondria affect intracellular Ca 2 þ metabolism in two ways: (i) directly by regulating both the amplitude, duration, location and propagation of cytosolic Ca 2 þ elevations and the recycling of Ca 2 þ towards the endoplasmic reticulum (ER) and 2 (ii) indirectly by producing ATP, which is used by Ca 2 þ -dependent ATPases to pump Ca 2 þ out of the cell (by the plasma-membrane Ca 2 þ ATPase: PMCA) or into intracellular stores (by the sarco-ER Ca 2 þ ATPase: SERCA). Conversely, Ca 2 þ entering to the mitochondrial matrix regulates mitochondrial metabolism through the activation of the Ca 2 þ -dependent enzymes of the Krebs cycle. 3 Leigh's syndrome is a rare but severe and fatal encephalopathy of early childhood that is most frequently associated with deficiencies in nucleus-encoded subunits of Complex I (NDUFS3 and NDUFS7), 4, 5 Complex II (SDHA), 6 Complex IV (SURF1) 7 or pyruvate dehydrogenase. 8 Despite the identification of the genetic origin of Leigh's syndrome, the molecular and cellular events associated with pathology are not completely understood.
Deregulations of intracellular Ca 2 þ signalling have been reported in different models of mitochondrial respiratory chain diseases, [9] [10] [11] whereas data on Complex II deficiency are still lacking.
Complex II (succinate: ubiquinone (UQ) oxidoreductase) has a central function in oxidative metabolism, being an important enzyme of the citric acid cycle as well as a Complex of the mitochondrial respiratory chain. 12 We report here the cellular events deriving from Complex II mutation associated with Leigh's syndrome. This study was conducted also in cellular models in which we mimicked Complex II deficiency by using Complex II inhibitors. We showed broad subcellular Ca 2 þ signalling alterations occurring before cell demise in Complex II-deficient cells. Interestingly, we showed that cytosolic and mitochondrial Ca 2 þ overload are linked to SERCA and PMCA degradation occurring in a proteasome-dependent manner. Our study also revealed a dual function of Ca 2 þ deregulation in the control of cellular bioenergetics outcome and mitochondrial pathology.
Results
We studied fibroblasts isolated from a patient with Leigh's syndrome harbouring a homozygous Arg554Trp substitution in the Fp subunit of the Complex II (SDHA R554W ). 13 These fibroblasts were shown to present a reduction of Complex II activity to B30% of control values. 13 Leigh's syndrome associated with Complex II mutations was described in very rare cases. 6 To bypass this limitation, we conducted the whole study using two inhibitors of Complex II (3-NP (3-nitropropionic acid) or Atpenin A5 14, 15 ) in both fibroblasts derived from healthy individuals and the neuronal-derived cell line (SH-SY5Y). 3-NP is structurally similar to Complex II substrate succinate thus interacting with some residue in the active site of the enzyme.
14 Atpenins were shown to share structural similarity with UQ thus blocking the electron transfer between the enzyme and UQ by binding to a region that partly overlaps with the physiological UQ-binding site. 15 To note, we deliberately used (i) concentrations of 3-NP (300 mM) and Atpenin A5 (100 nM), which did not induce cell death at 20 h thus affording to study Complex II deficiency independently from cell death (Supplementary Figure S1a) and (ii) extended application (20 h) of the drugs to chronically inhibit Complex II (Supplementary Figure S1b) . Importantly, under these conditions, Complex II activity was reduced to 15-40% of control values in both mutated cells and control fibroblasts and SH-SY5Y cells (Supplementary Figure S1b and Table S1 ). Application of 3-NP or Atpenin A5 at the same concentrations for 72 h or application of 1 mM 3-NP for 20 h determined cell death showing that Complex II inhibition is linked to cell death (Supplementary Figure S1c and 1d right) .
To show that in our conditions we mimicked chronic Complex II inhibition on drug application, we measured Complex II activity at 6 and 20 h after treatment with 300 mM 3-NP. Interestingly, reduction of Complex II activity occurred on 6 h of treatment and was maintained to a similar level on 20 h of treatment (data not shown).
We assessed mitochondrial functionality on Complex II mutation or inhibition. Mitochondrial potential (Dc mit ) was measured by using tetramethyl rhodamine methyl ester (TMRM) dye, which accumulates within the mitochondrial matrix as a function of Dc mit . As expected, we observed a significant decrease (B70% versus control considered as 100%) of Dc mit on Complex II mutation or inhibition in both fibroblasts and SH-SY5Y cells (Figures 1a and b , respectively; Supplementary Table S2) .
The mitochondrial respiratory chain is known to be the major source of reactive oxygen species (ROS) within the cell. 16 We measured mitochondrial production of superoxide (O 2 KÀ ) by using MitoSOX red-mitochondrial superoxide indicator. Complex II-deficient cells displayed an increase in mitochondrial O 2 KÀ production of almost 25% as compared with control ( Figure 1c ; Supplementary Table S3 ). The specificity of the test was confirmed by using the ROS scavenger pyrrolidine dithiocarbamate (PDCT) (Figure 1c ; Supplementary Table S3 ). This result is consistent with earlier reported data, which show increased activities of both mitochondrial and cytosolic inducible superoxide dismutase in SDHA R554W cells. Figure 2d ; Supplementary Table S8) .
Mitochondrial Ca 2 þ uptake and Dc mit are tightly crossregulated. 1 On the one hand, the main driving force for Ca 2 þ accumulation across the inner mitochondrial membrane is the electrochemical gradient (DmH) established and maintained by the respiratory chain, whereas, on the other hand, depolarization occurs transiently after Ca 2 þ uptake in physiological conditions. 1 We measured the kinetics of the Ca 2 þ and potential changes occurring in mitochondria of Complex II-deficient cells. Interestingly, we observed an increased agonist-evoked mitochondrial Ca 2 þ response as early as after 4 h of treatment with Complex II inhibitors (Figure 3a ; Supplementary Table S8 ). This result was observed with both inhibitors 3-NP and Atpenin A5 and in both fibroblasts and SH-SY5Y cells (Figure 3a ; Supplementary Table S8 ). In parallel, no modification of Dc mit was noticed in cells treated in the same conditions (Figure 3b ; Supplementary Figure S2b) .
Earlier data have shown that ER Ca 2 þ depletion can be linked to the induction of the unfolded protein response (UPR). 18 However, our data revealed no induction of UPR in SDHA R554W cells (Supplementary Figure S3) .
Finally, no clear modification of capacitative Ca 2 þ entry was noted in SDHA R554W -mutated cells as compared with controls ( Figure 4d) To investigate the molecular mechanisms underlying the intracellular Ca 2 þ overload related to Complex II deficiency, we analysed SERCA and PMCA expression in Complex II-deficient cells by western blotting. SH-SY5Y cells are known to express mostly SERCA2b and PMCA2 isoforms. As shown in Figure 5a , a significant decrease of SERCA2b and PMCA2 expression was observed in SDHA R554W cells and in SH-SY5Y cells on Complex II inhibition ( Figure 5a ). Interestingly, a similar result was observed on inhibition of mitochondrial ATP synthase by Oligomycin (Figure 5a ).
SERCA and PMCA down-regulation could be due to reduced transcription level or increased rate of degradation. By using semi-quantitative RT-polymerase chain reaction (PCR), we showed that SERCA2b and PMCA2 transcription level is not altered on Complex II or ATP synthase inhibition ( Figure 5b ). We then investigated SERCA2b and PMCA2 degradation. SH-SY5Y cells were treated with the protein synthesis inhibitor cyclohexemide (CHX) in the presence or not of 3-NP or Oligomycin. Kinetic analyses revealed a rapid degradation of both SERCA2b and PMCA2 on Complex II or ATP synthase (Figure 5c ) inhibition. To determine whether SERCA2b and PMCA are degraded by the proteasome, we treated the cells with the proteasome inhibitor MG132 for 2 h and then applied CHX alone or in the presence of 3-NP and Oligomycin for 1 h. As shown in Figure 5d These data reveal the involvement of the proteasomedependent degradation pathway in SERCA2b and PMCA2 down-regulation. The result obtained on ATP synthase blockade by Oligomycin may reveal that rapid degradation of SERCA2b and PMCA2 is an ATP-dependent mechanism. Overall, these data suggests that cytosolic and mitochondrial Ca 2 þ overload on Complex II deficiency are a consequence of suppressed cytosolic Ca 2 þ extrusion through the plasma membrane and accumulation in the ER by PMCA and SERCA, respectively.
As mitochondrial Ca 2 þ overload is a major actor triggering mitochondrial structure alteration and swelling, we analysed the mitochondrial structure in the context of Complex II defect. High-resolution imaging revealed no clear mitochondrial structure modification in Complex II-deficient cells as compared with controls (Supplementary Figure S4a) . Accordingly, mitochondrial volume was also not modified on Complex II mutation or inhibition in both fibroblasts and SH-SY5Y cells (Supplementary Figure S4b) . These data are in accordance with the absence of apoptosis in both models and showed also that increased mitochondrial Ca 2 þ content is not associated with increased mitochondrial biogenesis (as estimated by unchanged volume).
It has been shown that elevated Ca 2 þ signals in microdomains between mitochondria and ER Ca 2 þ release sites immobilize mitochondria close to the ER, thus increasing Ca 2 þ transfer between the organelles. 19 As we showed that Complex II mutation induced on the one hand an increased ER Ca 2 þ leak and on the other hand an elevation of mitochondrial Ca 2 þ load (Figures 2b, d and 4), we tested whether these modifications are associated with mitochondrial movement inhibition and ER-mitochondria increased contact sites. High-resolution time-lapse imaging of the mitochondrial network revealed a significant reduction of mitochondrial movements on Complex II mutation or inhibition in both fibroblasts and SH-SY5Y cells (Figure 6a ; Supplementary Table S10 ). Accordingly, high-resolution imaging revealed an increase of the extent of association between ER and mitochondria on Complex II deficiency (Figure 6b ; Supplementary Table S11) .
We then investigated the impact of Ca 2 þ deregulation on cellular bioenergetics and mitochondrial dysfunction related to Complex II deficiency.
Measurement of total ATP level on total cell homogenates revealed increased total [ATP] in SDHA R554W fibroblasts and in control fibroblasts treated with Atpenin A5 (B þ 15% versus control) (Figure 7a (Figure 7c ; Supplementary Table S13 ). Interestingly, the extent of ATP reduction was larger in Complex II-deficient cells as compared with controls (72% in control, 60% in SDHA R554W and 65% in Atpenin A5) (Figure 7c ; Supplementary Table S13) .
The data presented in Figure 1 showed an overt mitochondrial pathology on Complex II deficiency. Different Figure  S5a) and reduction of mitochondrial Ca 2 þ load (Supplementary Figure S5b ). These processes are known as markers of mitochondrial outer membrane permeabilization and swelling accompanying cell death.
Discussion
By studying fibroblasts isolated from a patient affected by Leigh's syndrome harbouring respiratory chain Complex II (SDHA R554W ) mutation 13 and fibroblasts and neuronalderived cells chronically treated with Complex II inhibitors, we reported subcellular Ca 2 þ deregulations occurring before cell death and showed that Complex II deficiency induced a deep regulation of Ca 2 þ signalling-dependent bioenergetics and mitochondrial dysfunction, which control cellular fate. Only few studies have been focusing on the study of Complex II inhibition and none has provided a global assessment of subcellular Ca 2 þ signalling before cell death. These studies reported that inhibition of Complex II by 3-NP enhances basal and NMDA-induced intracellular [Ca 2 þ ] in neurons, 23, 25, 26 potentially leading to Dc mit loss, mitochondrial structure alteration, ROS production and cell death. 23, 26, 27 The parallel and thorough investigation of subcellular Ca 2 þ and bioenergetics alterations on Complex II mutation or chronic inhibition allowed us to reveal the following pattern ( Figure 8 signals in different models of mitochondrial respiratory chain diseases (i.e. in MELAS: mitochondrial encephalopathy, lactic acidosis and stroke-like episodes, 10 and MERRF: myoclonic epilepsy and ragged-red fibres, 9 and in Complex I-mutated fibroblasts 11 ). To note, our study was conducted in models before cell death thus revealing primary Ca 2 þ deregulation events occurring on Complex II deficiency.
We showed that cytosolic and mitochondrial Ca 2 þ overload linked to Complex II deficiency are likely to be due to rapid degradation of SERCA2b and PMCA2 occurring in a proteasome-dependent manner. This phenomenon is predictably related to the decreased mitochondrial ATP production, as SERCA2b and PMCA2 degradation was also observed on ATP synthase inhibition. Complex II-dependent SERCA2b and PMCA2 degradation occurs despite the slight increase of glycolysis-dependent, cytosolic [ATP] pointing out a primary function of mitochondrial ATP in the degradation process. Indeed, mitochondrial ATP is considered the major cellular Tables S13-15) ATP source. Alternatively, and not exclusively, the proximity between mitochondria and plasma and/or ER membranes could explain the sensitivity of SERCA2b and PMCA2 to mitochondrial ATP production. Accordingly, the existence of ATP micro-domains beneath the plasma membrane and in ER-mitochondria contact sites has been already shown in some cell models. 29, 30 Proteasome-dependent degradation of SERCA2a isoform was reported in an earlier work by Ihara et al. 31 Ubiquitination of PMCA1 isoform has also been detected after preconditioning ischaemia in rat cortical neuronal cultures. 32 As polyubiquitylated proteins are the preferred proteasome 26S substrates, we postulate that SERCA2b and PMCA2 undergo proteasome-dependent degradation after their ubiquitination.
It is known that ATP/Mg 2 þ regulates the 26S proteasome activity, its assembly and stability. 33 However, Geng et al.
34
showed that a subset of 26S proteasome is activated as ATP levels decline. Thus, in the context of Complex II deficiency, mitochondrial ATP depletion may have favoured the activation of a subset of 26S proteasome leading to SERCA2b and PMCA2 degradation. Increased total ATP production has been recently reported in MELAS syndrome linked to Complex I ND5 gene mutation. 35 In this study, glycolytic ATP has been shown to be consumed by mitochondria to maintain Dc mit . In addition, Ca 2 þ -dependent activation of anaerobic glycolysis and increased cytosolic ATP have been recently described during apoptotic cell death. 21 As our study was conducted before cell death, increased glycolysis-dependent [ATP] may be a compensatory mechanism to the decreased oxidative phosphorylation-dependent ATP production. This phenomenon is Ca 2 þ dependent as we showed that Ca 2 þ chelation by BAPTA, AM reversed glycolytic-dependent ATP production. Thus, the increase of intracellular Ca 2 þ signals may be considered as a first attempt to delay cellular pathology through the activation of glycolytic-dependent ATP production.
Our study revealed a double hint of Ca 2 þ signalling deregulation in Complex II-deficient cells as besides increasing glycolytic ATP production, Ca 2 þ overload favoured mitochondrial pathology. Thus, depending on their energetic needs, cells with Complex II defect may thus undergo a progressive mitochondrial dysfunction, characterized by Dc mit loss, Ca 2 þ overload and increased ROS, eventually leading to cell death (Supplementary Figure S5) . As a matter of fact, neuronal loss was reported in the brain of the patient harbouring SDHA R554W mutation. 36 Materials and Methods Chemicals. Culture material was obtained from Invitrogen (SARL, Cergy Pontoise, France), coelenterazine, and fluorescent dyes from Molecular Probes (Invitrogen, SARL), and Atpenin A5 from Coger (eMarketLabo.com). All the other reagents and chemicals were from Sigma-Aldrich (Sigma-Aldrich, SARL, Lyon, France).
Cell culture. Fibroblasts were grown as already described. 17 Human SH-SY5Y neuroblastoma cells (CRL-2266: ATCC, Manassas, VA, USA) were cultured following manufacturer's instructions.
Aequorin measurements. To bypass low transfection efficiency of fibroblasts and SH-SY5Y cells, we used the earlier described adenoviral system expressing cytosolic (AdCMVcytAEQ)-, mitochondrial (AdCMVmitAEQmut and AdCMVmitAEQwt)-, and ER (AdCMVerAEQ)-targeted aequorin probes. [37] [38] [39] For infection, B20000 cells (fibroblasts) and 150000 cells (SH-SY5Y) were spotted on 13-mm coverslips, and placed 24 h later in contact with the appropriate virus (10 5 infectious particles/ml). Aequorin measurements were performed 48 h post-infection. Specific targeting of adenoviral aequorin probes to desired organelles was verified by immunohistochemistry (Supplementary Figure S6) .
MitAEQ and cytAEQ were reconstituted with 5 mM coelenterazine for 2 h in Krebs-Ringer-modified buffer (KRB: 125 mM NaCl, 5 mM KCl, 1 mM Na 3 PO 4 , 1 mM MgSO 4 , 5.5 mM glucose and 20 mM Hepes, pH 7.4) supplemented with 1 mM CaCl 2 (KRB/CaCl 2 ) at 371C. Cytosolic and mitochondrial signals were obtained on application of 100 mM Histamine (fibroblasts) or 500 mM Carbachol (SH-SY5Y).
Capacitative Ca 2 þ entry analyses were performed by using cytosolic (AdCMVcytAEQ)-aequorin probe. Cells transferred to the luminometer were treated as specified in the legend of the figure.
For reconstitution with high efficiency of the erAEQ, the luminal [Ca 2 þ ] of this compartment was first reduced. This was achieved by incubating the cells for 1 h at 41C in KRB supplemented with 5 mM n-coelenterazine, 1 mM Ca 2 þ ionophore ionomycin and 600 mM EGTA. After this incubation, cells were extensively washed with KRB supplemented with 2% bovine serum albumin before the luminescence measurement was initiated. The ER was refilled by exposing the cells to extracellular 1 mM CaCl 2 . After reaching the steady state value, agonist-evoked Ca 2 þ release was initiated by application of agonists. The SERCA blocker, TBuBHQ (2, 5 -Di (tert-butyl) -1, 4-benzohydroquinone) was used to initiate the release of stored Ca 2 þ and thus to analyse ER Ca 2 þ leak. All aequorin measurements were carried out in a purpose built luminometer. The experiments were terminated by lysis of the cells with 100 mM digitonin in a hypotonic Ca 2 þ -rich solution (10 mM CaCl 2 in H 2 O), thus discharging the remaining aequorin pool. The light signal was collected and calibrated into [Ca 2 þ ] values, as earlier described. 18 On the basis of the experimental traces, the maximum rates of ER Ca 2 þ uptake were measured from the first derivative of the ascending refilling phase obtained after CaCl 2 addition, and the maximum rates of ER Ca 2 þ leak were measured from the first derivative of the curve on addition of TBuBHQ using Origin 5 software. Fitting of the curve was performed using Microsoft Excel software. 
Measurements of mitochondrial superoxide concentration.
MitoSOX red is a novel fluorogenic dye for highly selective detection of superoxide in the mitochondria of living cells. Cells spotted on 24-mm coverslips were loaded with 5 mM MitoSOX red prepared in a KRB/1 mM CaCl 2 at 371C for 30 min. After a brief washout, Z-stack images were acquired on a Zeiss LSM 510 confocal microscope (Carl Zeiss). Dye intensity was quantified on maximal projection of Z-stack images after thresholding, using the Zeiss LSM and ImageJ softwares. We presented data as mean fluorescence intensity of oxidized MitoSOX. We assume that MitoSOX probe give a semi-quantitative detection and not an absolute estimation of mitochondrial superoxide value. Importantly, as control, we used the ROS scavenger PDCT to show the specificity of this probe.
Imaging analyses. For the measurement of mitochondrial movements or mitochondrial potential (Dc mit ), images were acquired on a Zeiss LSM 510 confocal microscope after loading the cells with 10 nM Mitotracker red (movement analysis) or 20 nM TMRM (Dc m analysis) in KRB/1 mM CaCl 2 at 37 1C for 30 min.
For mitochondria movement analysis, time series images were taken with a time interval of 5 s between each image. Images were 2D-deconvolved, median filtered, thresholded and clipped to 8-bit binary images using Metamorph (Universal Imaging) software. Using the stack-T-functions/Delta-F-down plugin of the WCIF ImageJ software (http://www.uhnres.utoronto.ca/facilities/wcif/), pixels in each frame were subtracted from the next frame. The resulting images were quantified by measuring the total area of object on the binary and DF images by the integrated morphometry analysis function of the Metamorph software. Data were normalized as the ratio of DF area values over the total area of the original binary images for each cell. This parameter is referred to as the mitochondrial movement index. 18 Binarization and normalization were applied to avoid artefacts eventually arising from changes of intensity and focal plane.
To obtain normalized TMRM fluorescence signal, time-lapse images were acquired on a Zeiss LSM 510 confocal microscope. Images were acquired before and after application of 10 mM mitochondrial uncoupler FCCP. To show specific TMRM binding, measurements were routinely corrected for residual TMRM fluorescence after full Dc mit collapse with FCCP. Basal TMRM signal was normalized to the remaining signal obtained on FCCP application and presented as f/f 0 where f is the mean of basal TMRM intensity along 10 s in the plateau phase and f 0 is the mean of TMRM intensity along the baseline after FCCP application.
For analyses of ER-mitochondria contact sites, cells were transfected with erGFP and loaded with Mitotracker Deep Red. The spectral properties of these two fluorochromes allow specific identification of the two compartments and quantification of contact sites. 16-bit images were acquired with a pixel size equal or lower to the maximal resolution of the 63X objective to allow optimal detection of colocalized pixels on the stage of a Leica SP5 confocal microscope. ER and mitochondria colocalization was calculated as the number of voxels (volume pixels) occupied by both signals (i.e. erGFP and Mitotracker Deep Red) over all voxels occupied by the mitochondria (Mitotracker Deep Red signal) in thresholded images using Imaris software.
Protein preparation and western-blot analyses. Plasma membrane and microsomal fractions were isolated as already described.
18,40 SDS-PAGE was then performed. The signal was revealed using ECL Plus western-blot detection reagent (Amersham Biosciences, Orsay, France).
For the experiments shown in Figures 5c and d , membrane fraction obtained as already described 18 was used to reveal both SERCA and PMCA. Protein synthesis was inhibited using 100 mM CHX alone or in the presence of 300 mM 3-NP or 5 mM Oligomycin for the indicated time points. Proteasome-dependent degradation of SERCA2b and PMCA2 was assessed using proteasome inhibitor MG132. After 2 h pre-incubation of SH-SY5Y cells with or without MG132 (5 mM), cells were treated for 1 h with 100 mM CHX in the presence or not of 300 mM 3-NP or 5 mM Oligomycin. Loading control was assessed using a-tubulin, GRP94 as a marker of a resident ER protein and cadherin as a marker of a resident plasma-membrane protein. Similar result was obtained using these loading controls. Only the result of a-tubulin is shown.
RNA extraction and RT-PCR analysis. Total RNA was extracted using RNeasy Mini kit (Qiagen, Courtaboeuf, France); 1 mg of total RNA was used for reverse transcription using High-Capacity cDNA Archive kit (Applied Biosystems, Courtaboeuf, France) with random hexamer primers according to the manufacturer's protocol. The final reaction volume was 25 ml. The reaction tubes were incubated at 25 1C for 10 min, 120 min at 37 1C and 5 min at 851C. The primers for PCR for PMCA2 transcript were forward: TCCCGACC AGCAGACTCAAGTT, reverse: CGAGTTCTGCTTGAGCGCGG (fragment size: 350 bp). For SERCA 2b transcript, the following primers were used: forward: TTTCCTACAGTGTAAAGAGGACAACC, reverse: AGACCAGAACATATCGCTA AAGTT (fragment size: 514 bp). PMCA and SERCA2b transcript levels were normalized to GAPDH transcript level amplified using forward: CTTCATTG ACCTCAACTACATGGT, reverse: CTCAGTGTAGCCCAGGATGCCCTT (fragment size: 727 bp). PCR was performed using 0.5 ml of the reverse transcription mixture in a final volume of 50 ml containing: 1 Â Green GoTaq buffer, primers (10 mM each) and Gren Go Taq Hot start polymerase (2.5 U) and dNTP (10 mM each). PCR amplification cycles were run using a thermal cycler (PerkinElmer, Courtaboeuf, France) as following: denaturation at 951C, 5 min; annealing at 601C, 1 min; extension at 721C, 1 min, and heating at 721C, 10 min. For semi-quantitative PCR, three different amplification cycles were used; see figure legend. Relative signal intensities were quantified using NIH Image J software and are shown in graphs.
Statistical analyses. The results are reported from at least three different experiments. Statistical analyses were performed using ANOVA. Bonferroni's post hoc analysis was subsequently performed on ANOVA results to determine significance. Bonferroni's t-test was calculated versus respective control (Supplementary Tables S1-11 ) and graphs in Figure 5 or all pairwise (Supplementary  Tables S12-15) .
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